Advertisement

BMC Medicine

, 14:214 | Cite as

Erratum to: Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

  • WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group
Open Access
Erratum

Erratum

After publication of the original article [1], it came to the authors’ attention that there is an error in the originally-published version of Fig. 2. The labelling of the x-axis for Fig. 2 is not correct. The last two values of the x-axis should read: “5-11” instead of “5”, and “12+” instead of “6”.
Fig. 2

Measured day 7 lumefantrine concentrations in patients given supervised treatment with the recommended six-dose artemether-lumefantrine regimen, by age and nutrition status. Concentrations are dose-adjusted and scaled for a total dose of 72 mg/kg (after excluding patients with quantifiable lumefantrine concentrations pre-treatment). Outside values are not shown

The correct version of Fig. 2 is published in this erratum.

Reference

  1. 1.
    WWARN Lumefantrine PK/PD Study Group. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med. 2015;13:227. doi: 10.1186/s12916-015-0456-7.

Copyright information

© The Author(s). 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group
    • 1
    • 2
  1. 1.WorldWide Antimalarial Resistance Network (WWARN)OxfordUK
  2. 2.Division of Clinical Pharmacology, Department of MedicineUniversity of Cape TownCape TownSouth Africa

Personalised recommendations